| |
|
|
| 20th EFORT Instructional Course, Budapest Hungary |
 Rendezvény kezdete: 2008.04.18. | Rendezvény vége: 2008.04.19. |
| Szervező: Mr. Patrick Collet |
| Munkahely neve: EFORT Central Office |
| Címe: 8005, Zurich, Technoparkstrasse 1. , Switzerland |
| Tel: +41 (0)444484400 |
| E-mail: patrick.collet@efort.org |
| Helyszín: 1145 Budapest, Róna utca 192-202., Uzsoki Kórház |
We are looking forward to welcoming orthopaedic surgeons from around Europe to the Uzsoki Hospital for the 20th EFORT IC - Instructional Course, which will be held for the second time in Hungary's wonderful capital city of Budapest.
Facts and Figures:
Main topics:
- ACL reconstruction
- MIS total knee replacement
- New advances in cartilage repair
- MIS total hip replacement
Uzsoki Hospital is a leading centre for joint reconstruction surgery, with a specific focus on arthroscopic procedures, including cartilage reconstruction, ACL surgery and different techniques for realignment operations. Minimally invasive techniques have become very popular in recent years. Uzsoki was one of the first centres to introduce MIS hip and knee arthroplasty in Hungary. Revision arthroplasty has also attracted significant scientific and technical interest.
Four live surgeries will demonstrate expert techniques and tips for mosaicplasty, double-bundle ACL reconstruction, and MIS hip and knee replacement.
With its practical subject matter, the course is aimed at orthopaedic and trauma surgeons from all over Europe.
Our course brings together participants from a variety of different countries and thus provides an excellent opportunity to establish new contacts among your peers and broaden your personal horizons.
For detailed information on the programme click here >>
We look forward to receiving your registration at http://www.efort.org/ – and to seeing you in Budapest! |
|
|
 |
| |
| Magyar Kardiológusok Társasága |
|
| Román Kardiológusok Társasága Kongresszusa |
| Rendezvény kezdete: 2012.10.04. | Rendezvény vége: 2012.10.06. |
| Helyszín: Románia, Sinaia, |
A több mint negyven külföldi előadó részvételével megrendezendő kongresszuson sok teljesen angol nyelvű szekció lesz, de mivel a román nyelvű előadásokhoz is kötelező angol nyelvű diasort készíteni, így a program a külföldi érdeklődők számára is érdekes lehet.
A Román Kardiológusok Társasága tíz 36 év alatti magyar kardiológus részére biztosít ingyenes regisztrációt kongresszusára. A fiatal kollégáknak maguknak kell gondoskodni a szállásról illetve az utazásról, melyek intézésében szívesen segítenek a szervezők.
Azok a 36 év alatti fiatal kardiológusok, akik szeretnék kérni az ingyenes kongresszusi regisztrációt a román kongresszusra, küldjék önéletrajzukat az MKT Titkárságára június 27-ig a tunde.czetenyi@mkardio.hu –ra. |
|
|
|
| |
|
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
